688331 榮昌生物
按盤價 
33.140 -0.420 (-1.251%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -36.908 | -35.907 | -23.706 | 7.847 | -41.500 |
| 總資產報酬率 ROA (%) | -19.063 | -26.170 | -19.623 | 6.675 | -29.033 |
| 投入資產回報率 ROIC (%) | -22.255 | -30.278 | -22.301 | 7.336 | -37.660 | 邊際利潤分析 |
| 銷售毛利率 (%) | 79.754 | 77.432 | 64.766 | 95.175 | 24.222 |
| 營業利潤率 (%) | -87.343 | -138.651 | -128.900 | 21.245 | -23,133.091 |
| 息稅前利潤/營業總收入 (%) | -84.536 | -140.043 | -138.154 | 18.503 | -20,912.088 |
| 淨利潤/營業總收入 (%) | -88.630 | -139.547 | -129.364 | 19.368 | -22,922.205 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.355 | 102.567 | 112.858 | 63.826 | 109.883 |
| 價值變動淨收益/利潤總額(%) | -0.183 | -0.462 | -1.212 | 0.000 | -0.041 |
| 營業外收支淨額/利潤總額(%) | 1.453 | 0.642 | 0.359 | -9.692 | -0.920 | 償債能力分析 |
| 流動比率 (X) | 1.356 | 1.976 | 3.663 | 3.758 | 7.004 |
| 速動比率 (X) | 0.956 | 1.318 | 3.067 | 3.300 | 6.848 |
| 資產負債率 (%) | 58.537 | 37.823 | 17.287 | 17.138 | 12.703 |
| 帶息債務/全部投入資本 (%) | 48.811 | 24.653 | 2.168 | 4.113 | 3.635 |
| 股東權益/帶息債務 (%) | 98.942 | 295.139 | 4,368.385 | 2,265.230 | 2,580.590 |
| 股東權益/負債合計 (%) | 70.833 | 164.386 | 478.465 | 483.513 | 687.213 |
| 利息保障倍數 (X) | -20.646 | 282.448 | 15.718 | -21.383 | -10.403 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.590 | 83.057 | 47.638 | 0.583 | 125.065 |
| 存貨周轉天數 (天) | 820.192 | 931.109 | 531.299 | 906.380 | 7,603.765 |
| 備註： | 即時報價更新時間為 15/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
